Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Cash Flow Quality Index

Latest as of September 2023: -0.95x

Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Cash Flow Quality Index of -0.95x as of September 2023. Operating cash flow of $-10.75 Million is below net income of $11.28 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Artiva Biotherapeutics, Inc. Common Stoc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.95x

Operating CF / Net Income

Operating Cash Flow

$-10.75 Million

USD

Net Income

$11.28 Million

USD

Data as of

Sep 2023

Most recent filing

Annual Cash Flow Quality Index for Artiva Biotherapeutics, Inc. Common Stock (None–None)

Year-by-year earnings quality comparison for Artiva Biotherapeutics, Inc. Common Stock.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.